(EMHC) SPDR Bloomberg Barclays - Ratings and Ratios
Emerging, Markets, Dollar-Denominated, Sovereign, Corporate, Bonds
Dividends
| Dividend Yield | 5.81% |
| Yield on Cost 5y | 6.30% |
| Yield CAGR 5y | 16.93% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 5.26% |
| Value at Risk 5%th | 8.67% |
| Relative Tail Risk | 0.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.01 |
| Alpha | 4.50 |
| CAGR/Max DD | 1.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.414 |
| Beta | 0.235 |
| Beta Downside | 0.235 |
| Drawdowns 3y | |
|---|---|
| Max DD | 7.96% |
| Mean DD | 1.66% |
| Median DD | 1.14% |
Description: EMHC SPDR Bloomberg Barclays October 29, 2025
The SPDR Bloomberg Barclays Emerging Markets USD Bond ETF (EMHC) seeks to track its benchmark by investing at least 80 % of assets in the index constituents or in securities the adviser judges to have “substantially identical” economic characteristics; the fund is classified as non-diversified, meaning concentration risk may be higher than a broadly diversified ETF.
Key metrics as of the latest filing show an average effective duration of roughly 4.5 years, a weighted-average yield near 6.8 %, and a credit-quality distribution of about 70 % sovereign exposure and 30 % corporate exposure. The fund’s performance is highly sensitive to emerging-market GDP growth rates, US dollar strength, and global interest-rate policy, with sovereign debt from countries like Brazil and Indonesia typically representing the largest holdings.
For a deeper quantitative breakdown and scenario analysis, you might find ValueRay’s platform useful for extending this initial view.
What is the price of EMHC shares?
Over the past week, the price has changed by +0.41%, over one month by +0.78%, over three months by +2.80% and over the past year by +11.89%.
Is EMHC a buy, sell or hold?
What are the forecasts/targets for the EMHC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 28.3 | 10.4% |
EMHC Fundamental Data Overview December 11, 2025
Beta = 1.02
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 229.6m USD (229.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 229.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 229.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.88% (E(229.6m)/V(229.6m) * Re(6.88%) + (debt-free company))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for EMHC ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle